Company Name | UMN Pharma Inc. |
---|---|
Incorporated | April 20, 2004 |
Paid in Capital | 90 million yen(As of December7, 2020) |
Business contents | Development and manufacture of biopharmaceuticals |
Representative Director & CEO | Kazufumi Katayama |
Akita Office and Akita Plant |
4-2-3, Gosyonoyumoto, Akita, Akita 010-1415, Japan |
Tokyo Headquarters | 7F, Tekko Building, 1-8-2, Marunouchi, Chiyoda-ku, Tokyo 100-0005, Japan TEL +81-3-5219-7325 FAX +81-3-3214-6003 |
Yokohama Research Center |
610-1, Nippa-cho, Kohoku-ku, Yokohama, Kanagawa 223-0057, Japan |
Akita Laboratory | Molecular Medicine Laboratory, Bioscience Education and Research Center, Akita University, 1-1-1, Hondo, Akita, Akita 010-8543, Japan |